Atlas FDA

LIPOSORBER LA-15 SYSTEM

FDA premarket approval P910018/S015 · decided 2012-05-03

Approval details

PMA number
P910018
Supplement
S015
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
LIPOSORBER LA-15 SYSTEM
Generic name
Lipoprotein, low density, removal
Applicant
Kaneka Pharma America Corp.
Date received
2011-11-08
Decision date
2012-05-03
Days to decision
177 days
Decision code
APPR
Product code
MMY
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
New York, NY
Statement
APPROVAL FOR MODIFICATIONS TO THE SULFLUX® KP-05 PLASMA SEPARATOR COMPONENT OF THE DEVICE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.